Please assess the completion status of the following clinical trial:

Trial Title: 48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic hepatitis B~* Biopsy performed within one year prior to screening or during screening~* ALT \> 1.5 x ULN~* HBeAg negative, anti-HBeAg positive~* HBV DNA \> 10E5 copies/ml~* Age 18-70 years~* Written informed consent~* Hepatic imaging without evidence of HCC~* All fertile males and females must be using two forms of effective contraception~Exclusion Criteria:~* Antiviral therapy against HBV within the previous 6 months; treatment with any investigational drug within 30 days of entry to this protocol~* Severe hepatitis activity as documented by ALT \> 10 x ULN~* Advanced liver disease~* Pre-existent leucopenia or thrombopenia~* Co-infection with HCV,HDV or HIV~* Other acquired or inherited causes of liver disease~* Alpha fetoprotein \> 50 ng/ml.~* Evidence of severe renal disease~* Hyper- or hypothyroidism~* Significant cardiovascular or pulmonary dysfunction, malignancy,immunodeficiency syndromes~* Immune suppressive treatment within the previous 6 months~* Contra-indications for alpha-interferon therapy~* Pregnancy, breast-feeding~* Any medical condition requiring chronic systemic administration of steroids~* Substance alcohol or drug abuse~* Subjects with clinically significant retinal abnormalities~* Subjects with clinically significant hearing abnormalities~* Hemoglobinopathies~* Subjects with known hypersensitivity to ribavirin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Ribavirin + Peg IFN
- 2 (Type: ACTIVE_COMPARATOR): Peg IFN + Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).